Search (News)

OSE Immunotherapeutics Confirms Marc Le Bozec As Chief Executive Officer To Lead Next Phase Of Strategic Growth

health top

(MENAFN - GlobeNewsWire - Nasdaq) Nantes, France, March 10, 2026 – 7:30am CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), today announced the transition of Marc Le Bozec from ...
2026-03-10 02:46:55